Q2 2025 Earnings Call Transcript July 23, 2025 Boston Scientific Corporation beats earnings expectations. Reported EPS is ...

For a moment, it appeared Boston Scientific was having a rare bumpy quarter. Executives in April had estimated tariffs would ...

Image Source: Zacks Investment Research Impressive Value-Adding Acquisitions: Boston Scientific’s recent acquisitions have added numerous products with immense potential. The company’s recently ...

Boston Scientific (NYSE: BSX) announced today that CMS granted reimbursement for its Agent drug-coated balloon (DCB).

Boston Scientific expects adjusted EPS to range between $2.95 and $2.99 for the full year. That marks a significant rise from ...

Nashville General Hospital says it won't deactivate the device because it "has no role in State executions." ...

When considering lead replacement, physicians should weigh the risks and benefits of extraction versus abandonment.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Boston Scientific Corporation (NYSE:BSX) is one of the biggest medical device companies in the world. Its shares have gained ...

Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks.

Abbott is doubling down on the structural heart space as it aims to gain ground in valve replacements following the recent global exit of Boston Scientific. CEO Robert Ford said sales of its ...